Bulletin
Investor Alert

ICU Medical Inc.

NAS: ICUI

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Oct 22, 2021, 4:09 p.m.

/zigman2/quotes/208026181/composite

$

225.94

Change

0.00 0.00%

Volume

Volume 4,451

Quotes are delayed by 20 min

/zigman2/quotes/208026181/composite

Previous close

$ 230.50

$ 225.94

Change

-4.56 -1.98%

Day low

Day high

$219.57

$228.00

Open

52 week low

52 week high

$176.19

$282.00

Open

Insider Actions for ICU Medical Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
09/15/2021 Robert S. Swinney
Director
2,157   Disposition at $243 per share. 524,151
09/14/2021 George A. Lopez
Director
15,295   Derivative/Non-derivative trans. at $46.53 per share. 711,676
09/14/2021 Elisha Wade Finney
Director
2,424   Derivative/Non-derivative trans. at $101.06 per share. 244,969
09/14/2021 Elisha Wade Finney
Director
2,424   Disposition at $242.2 per share. 587,092
09/10/2021 Virginia Sanzone
VP, General Counsel
248   Disposition at $252.82 per share. 62,699
09/10/2021 Virginia Sanzone
VP, General Counsel
401   Disposition at $251.27 per share. 100,759
09/10/2021 Virginia Sanzone
VP, General Counsel
151   Disposition at $250.23 per share. 37,784
06/03/2021 Robert S. Swinney
Director
207   Disposition at $204.04 per share. 42,236
06/03/2021 Robert S. Swinney
Director
1,293   Disposition at $202.95 per share. 262,414
06/03/2021 Robert S. Swinney
Director
215   Disposition at $204.08 per share. 43,877
06/03/2021 Robert S. Swinney
Director
2,485   Disposition at $203.07 per share. 504,628
06/03/2021 Robert S. Swinney
Director
300   Disposition at $202.16 per share. 60,648
06/03/2021 Robert S. Swinney
Director
1,500   Derivative/Non-derivative trans. at $39.38 per share. 59,070
06/03/2021 Robert S. Swinney
Director
1,500   Derivative/Non-derivative trans. at $43.62 per share. 65,430
05/24/2021 Vivek Jain
Chairman and CEO; Director
40   Gift at $0 per share. 0
05/20/2021 Vivek Jain
Chairman and CEO; Director
25   Gift at $0 per share. 0
05/11/2021 Robert S. Swinney
Director
468   Derivative/Non-derivative trans. at $0 per share. 0
05/11/2021 David C. Greenberg
Director
468   Derivative/Non-derivative trans. at $0 per share. 0
05/11/2021 Elisha Wade Finney
Director
468   Derivative/Non-derivative trans. at $0 per share. 0
05/11/2021 David F. Hoffmeister
Director
468   Derivative/Non-derivative trans. at $0 per share. 0
05/11/2021 Donald M. Abbey
Director
468   Derivative/Non-derivative trans. at $0 per share. 0
05/11/2021 Virginia Sanzone
VP, General Counsel
983   Disposition at $200.11 per share. 196,708
04/23/2021 George A. Lopez
Director
11   Disposition at $214.64 per share. 2,361
04/23/2021 George A. Lopez
Director
3,529   Disposition at $213.79 per share. 754,464
04/23/2021 George A. Lopez
Director
6,804   Disposition at $213.04 per share. 1,449,524
04/23/2021 George A. Lopez
Director
2,671   Disposition at $211.82 per share. 565,771
04/22/2021 George A. Lopez
Director
1,970   Disposition at $215.29 per share. 424,121
04/22/2021 George A. Lopez
Director
4,926   Disposition at $214.64 per share. 1,057,316
04/22/2021 George A. Lopez
Director
5,089   Disposition at $213.58 per share. 1,086,908
04/16/2021 George A. Lopez
Director
1,559   Disposition at $212.78 per share. 331,724
04/16/2021 George A. Lopez
Director
1,905   Disposition at $211.81 per share. 403,498
04/16/2021 George A. Lopez
Director
1,608   Disposition at $211.03 per share. 339,336
04/16/2021 George A. Lopez
Director
2,597   Disposition at $210.01 per share. 545,395
04/16/2021 George A. Lopez
Director
977   Disposition at $208.79 per share. 203,987
04/16/2021 George A. Lopez
Director
1,454   Disposition at $207.65 per share. 301,923

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
2 Purchases
5 Sales
17,719
5,381
Last 6 months
9 Purchases
13 Sales
23,059
10,929
Last 12 months
41 Purchases
94 Sales
203,737
273,678

Officers and Executives

Mr. Vivek Jain
Chairman & Chief Executive Officer
Mr. Christian Voigtlander
Chief Operating Officer
Mr. Brian M. Bonnell
Chief Financial Officer & Treasurer
Mr. Krishna Uppugonduri
VP-Quality, Medical & Regulatory Affairs
Ms. Virginia Sanzone
Secretary, Vice President & General Counsel
Mr. Daniel Woolson
Vice President & General Manager-Infusion Systems
Dr. George A. Lopez
Director
Ms. Laurie Hernandez
Director
Mr. Thomas D. McCall
VP-Marketing & Communications, GM-Critical Care
Mr. Kevin J. McGrody
Chief Accounting Officer
Mr. Clay Fradd
Vice President-Human Resources
Mr. David C. Greenberg
Lead Independent Director
Ms. Elisha Wade Finney
Independent Director
Mr. Donald M. Abbey
Independent Director
Mr. David F. Hoffmeister
Independent Director
Dr. Robert S. Swinney
Independent Director
Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.20%
  • /zigman2/quotes/201948298/composite BABA-5.69%
  • /zigman2/quotes/202092269/composite ENSC+36.10%
  • /zigman2/quotes/200164174/composite SNOA+74.50%
  • /zigman2/quotes/207683784/composite TIGR-10.38%
X
Powered by StockTwits
Link to MarketWatch's Slice.